WNS (WNS) Competitors

Medpace (NASDAQ:MEDP) and WNS (NYSE:WNS) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings.

Do analysts rate MEDP or WNS?

Medpace presently has a consensus price target of $406.60, suggesting a potential downside of 12.30%. WNS has a consensus price target of $68.13, suggesting a potential downside of 9.68%. Given WNS's stronger consensus rating and higher probable upside, analysts clearly believe WNS is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	3 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.93
WNS	0 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Which has more risk & volatility, MEDP or WNS?

Medpace has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, WNS has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500.

Does the media refer more to MEDP or WNS?

In the previous week, Medpace had 11 more articles in the media than WNS. MarketBeat recorded 20 mentions for Medpace and 9 mentions for WNS. Medpace's average media sentiment score of 1.28 beat WNS's score of 0.77 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	17 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
WNS	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals hold more shares of MEDP or WNS?

78.0% of Medpace shares are held by institutional investors. Comparatively, 97.4% of WNS shares are held by institutional investors. 20.3% of Medpace shares are held by company insiders. Comparatively, 2.0% of WNS shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has preferable earnings and valuation, MEDP or WNS?

Medpace has higher revenue and earnings than WNS. WNS is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.11B	6.18	$404.39M	$13.45	34.47
WNS	$1.35B	2.40	$170.11M	$3.59	21.01

Is MEDP or WNS more profitable?

Medpace has a net margin of 18.74% compared to WNS's net margin of 12.11%. Medpace's return on equity of 67.66% beat WNS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	18.74%	67.66%	21.86%
WNS	12.11%	22.90%	12.02%

Summary

Medpace beats WNS on 12 of the 15 factors compared between the two stocks.